• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性前列腺增生、组织学前列腺炎和前列腺癌中炎症及相关介质的差异研究。

Differential research of inflammatory and related mediators in BPH, histological prostatitis and PCa.

作者信息

Huang T R, Wang G C, Zhang H M, Peng B

机构信息

Department of Urology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

出版信息

Andrologia. 2018 Feb 14. doi: 10.1111/and.12974.

DOI:10.1111/and.12974
PMID:29441606
Abstract

Prostate cancer (PCa) is one of the most common male malignancies in the world. It was aimed to investigate differential expression of inflammatory and related factors in benign prostatic hyperplasia (BPH), prostate cancer (PCa), histological prostatitis (HP) and explore the role of Inducible nitric oxide synthase (iNOS), (VEGF) Vascular endothelial growth factor, androgen receptor (AR) and IL-2, IL-8 and TNF-α in the occurrence and development of prostate cancer. RT-PCR was used to detect the mRNA expression level of iNOS, VEGF, AR and IL-2, IL-8 and TNF-α in BPH, PCa and BPH+HP. Western blotting and immunohistochemical staining were used to detect the protein levels of various proteins in three diseases. The results showed the mRNA and protein levels of iNOS, VEGF and IL-2, IL-8 and TNF-α were significantly increased in PCa and BPH+HP groups compared with BPH group (p < .05), while the AR was significantly lower than those in PCa and BPH+HP groups (p < .05). There was no significant difference in the mRNA and protein levels of iNOS, VEGF, AR and IL-2, IL-8 and TNF-α between PCa and BPH+HP groups (p > .05). iNOS, VEGF, AR and IL-2, IL-8 and TNF-α are involved in the malignant transformation of prostate tissue and play an important role in the development and progression of Prostate cancer (PCa).

摘要

前列腺癌(PCa)是全球最常见的男性恶性肿瘤之一。旨在研究良性前列腺增生(BPH)、前列腺癌(PCa)、组织学前列腺炎(HP)中炎症及相关因子的差异表达,并探讨诱导型一氧化氮合酶(iNOS)、血管内皮生长因子(VEGF)、雄激素受体(AR)以及白细胞介素-2(IL-2)、白细胞介素-8(IL-8)和肿瘤坏死因子-α(TNF-α)在前列腺癌发生发展中的作用。采用逆转录聚合酶链反应(RT-PCR)检测BPH、PCa和BPH+HP中iNOS、VEGF、AR以及IL-2、IL-8和TNF-α的mRNA表达水平。采用蛋白质印迹法和免疫组织化学染色检测三种疾病中各种蛋白质的水平。结果显示,与BPH组相比,PCa组和BPH+HP组中iNOS、VEGF以及IL-2、IL-8和TNF-α的mRNA和蛋白质水平显著升高(p<0.05),而AR水平显著低于PCa组和BPH+HP组(p<0.05)。PCa组和BPH+HP组之间iNOS、VEGF、AR以及IL-2、IL-8和TNF-α的mRNA和蛋白质水平无显著差异(p>0.05)。iNOS、VEGF、AR以及IL-2、IL-8和TNF-α参与前列腺组织的恶性转化,在前列腺癌(PCa)的发生发展中起重要作用。

相似文献

1
Differential research of inflammatory and related mediators in BPH, histological prostatitis and PCa.良性前列腺增生、组织学前列腺炎和前列腺癌中炎症及相关介质的差异研究。
Andrologia. 2018 Feb 14. doi: 10.1111/and.12974.
2
Inflammation induced by lipopolysaccharide advanced androgen receptor expression and epithelial-mesenchymal transition progress in prostatitis and prostate cancer.脂多糖诱导的炎症促进了前列腺炎和前列腺癌中雄激素受体的表达以及上皮-间质转化进程。
Transl Androl Urol. 2021 Nov;10(11):4275-4287. doi: 10.21037/tau-21-964.
3
Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells.血管生成与前列腺癌:前列腺癌细胞在体内和体外血管生成因子的表达
Urology. 1998 Jan;51(1):161-7. doi: 10.1016/s0090-4295(97)00491-3.
4
[Influence of histological prostatitis on the clinical features of benign prostatic hyperplasia and prostate cancer].[组织学前列腺炎对良性前列腺增生和前列腺癌临床特征的影响]
Zhonghua Nan Ke Xue. 2014 Apr;20(4):354-8.
5
Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.前列腺癌、良性前列腺增生和无症状性炎性前列腺炎患者的氧化应激参数:一项前瞻性对照研究。
Adv Clin Exp Med. 2017 Oct;26(7):1095-1099. doi: 10.17219/acem/66837.
6
Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.催乳素和睾酮诱导的羧肽酶-D与前列腺癌中硝基酪氨酸和Ki67的增加相关。
Prostate. 2015 Nov;75(15):1726-36. doi: 10.1002/pros.23054. Epub 2015 Jul 22.
7
Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer.良性前列腺增生和前列腺癌中炎症网络的分析
Prostate. 2004 Feb 1;58(2):121-9. doi: 10.1002/pros.10317.
8
The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.良性前列腺增生症与前列腺癌之间的争议性关系:炎症的作用。
Eur Urol. 2011 Jul;60(1):106-17. doi: 10.1016/j.eururo.2011.03.055. Epub 2011 Apr 9.
9
Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF/TGFβ and iNOS/COX-2.非布司他对睾酮诱导的大鼠良性前列腺增生的改善作用:血管内皮生长因子/转化生长因子β及诱导型一氧化氮合酶/环氧化酶-2的作用
Eur J Pharmacol. 2020 Dec 15;889:173631. doi: 10.1016/j.ejphar.2020.173631. Epub 2020 Oct 5.
10
Asteris Radix et Rhizoma suppresses testosterone-induced benign prostatic hyperplasia in rats by regulating apoptosis and inflammation.紫菀根和根茎通过调节细胞凋亡和炎症抑制睾酮诱导的大鼠良性前列腺增生。
J Ethnopharmacol. 2020 Jun 12;255:112779. doi: 10.1016/j.jep.2020.112779. Epub 2020 Mar 21.

引用本文的文献

1
Plasma metabolites as mediators in the relationship between inflammation-related proteins and benign prostatic hyperplasia: insights from mendelian randomization.血浆代谢物作为炎症相关蛋白与良性前列腺增生关系的中介物:来自孟德尔随机化的见解。
Sci Rep. 2024 Oct 30;14(1):26152. doi: 10.1038/s41598-024-77515-2.
2
Diagnostic Performance of PI-RADS v2, Proposed Adjusted PI-RADS v2 and Biparametric Magnetic Resonance Imaging for Prostate Cancer Detection: A Preliminary Study.PI-RADS v2、拟议调整的 PI-RADS v2 和双参数磁共振成像在前列腺癌检测中的诊断性能:一项初步研究。
Curr Oncol. 2021 May 12;28(3):1823-1834. doi: 10.3390/curroncol28030169.
3
Estrogen regulates the proliferation and inflammatory expression of primary stromal cell in benign prostatic hyperplasia.
雌激素调节良性前列腺增生中初级基质细胞的增殖和炎症表达。
Transl Androl Urol. 2020 Apr;9(2):322-331. doi: 10.21037/tau.2020.02.08.
4
Retrospective Study of the Significant Predictive Role of Inflammatory Degree in Initial and Repeat Prostate Biopsy Specimens for Detecting Prostate Cancer.回顾性研究炎症程度在初次和重复前列腺活检标本中对前列腺癌检测的显著预测作用。
Cancer Res Treat. 2019 Jul;51(3):910-918. doi: 10.4143/crt.2018.314. Epub 2018 Oct 2.